Dupont Capital Management Corp Sells 9,288 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Dupont Capital Management Corp lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 30.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,925 shares of the healthcare conglomerate’s stock after selling 9,288 shares during the period. Dupont Capital Management Corp’s holdings in UnitedHealth Group were worth $10,585,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Delta Financial Group Inc. grew its stake in UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares in the last quarter. First PREMIER Bank boosted its stake in shares of UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 18 shares in the last quarter. Genesee Capital Advisors LLC boosted its stake in shares of UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares in the last quarter. Jmac Enterprises LLC boosted its stake in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares in the last quarter. Finally, Matrix Private Capital Group LLC boosted its stake in shares of UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $519.08 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $477.70 billion, a price-to-earnings ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62. The company’s 50 day moving average is $545.26 and its 200 day moving average is $564.10. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.75 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on UNH. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.